You searched for metabolic diseases - Page 35 of 64

News and Trends 23 Apr 2020

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

…Treg cell therapies for inflammatory and autoimmune diseases. Under the terms of the agreement, Mogrify will receive an undisclosed upfront payment from Sangamo and will also be eligible to receive…

April 23, 2020 - 3 minutesmins - By Laura Cowen

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

…recent outbreaks of diseases such as Ebola, SARS and now Covid-19 have been a wake-up call to both investors and governments about the importance of pandemic preparedness. As of May…

May 18, 2020 - 13 minutesmins - By Helen Albert

News and Trends 2 Jun 2022

Upstream Bio to target asthma as it launches with $200M financing

…program UPB-101, a clinical-stage monoclonal antibody targeting the thymic stromal lymphopoietin (TSLP) receptor. It added the investment will also help build a pipeline of assets to address immune-mediated diseases. The…

June 2, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 21 Jun 2016

UK Partnership is looking for new Epigenetic targets in Respiratory Disease

…for diseases like asthma. After partnering up with genomics elite for a new biobank, AstraZeneca is again preparing to tap into collaborations with academia. This time, the objective is to…

June 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 31 Oct 2022

Replay Bio launches HSV gene therapy company to target retinal eye disease

…addressing genetic eye diseases caused by large genes and genomic genes. “This will result in an increased variety of gene therapy options for patients with genetic eye diseases,” Mahajan said….

October 31, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 14 Sep 2022

Collaboration to explore gene therapy products for neurodegenerative disorders

Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop gene therapy proteins targeting protein degradation in neurodegenerative disorders. The IMN is a joint research…

September 14, 2022 - 3 minutesmins - By Liza Laws

More News! 10 Nov 2022

Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing

Breye Therapeutics ApS a biopharmaceutical company developing therapies for retinal vascular diseases today (November 10) has closed a seed financing of €4 million led by Novo Holdings and Sound Bioventures….

November 10, 2022 - 4 minutesmins - By Liza Laws

polyneuron anti mag peripheral neuropathy autoimmune disease nerve

News and Trends 28 Mar 2019

Swiss Biotech Raises €20M to Develop Decoy Drugs in Autoimmune Disease

…highly specific treatment approach is fundamentally new and could potentially enable treatment options for previously incurable diseases.” Healthy nerve cells (left) have support cells wrapped around them to help conduct…

March 28, 2019 - 2 minutesmins - By Jonathan Smith

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

…infectious diseases. Somewhat of a sleeping giant, the company has yet to bring a drug to market, which no doubt contributes to its falling market cap, now standing at €176M…

January 23, 2018 - 10 minutesmins - By Alex Dale

News and Trends 4 Jan 2018

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

…in the exciting field of microbiome-based therapies for diseases like inflammatory bowel diseases and cancer. This morning, the company has announced that it has raised €32M in a Series D…

January 4, 2018 - 3 minutesmins - By Alex Dale

In Depth 4 Nov 2020

The Return of Gene Therapy

…a smooth one. Gene therapy has been one of the biggest success stories of the 21st century. Genetic diseases were once seen as incurable, etched in stone (or rather, in…

November 4, 2020 - 8 minutesmins - By Farhan Mitha

News and Trends 21 Jan 2016

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

Neovacs in Paris (France) investigates immunotherapies for the treatment of autoimmune diseases and today signed a partnering agreement with the molluscan protein manufacturer, Stellar Biotechnologies (US). This joint venture will…

January 21, 2016 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

Will Covid-19 Change the Face of Vaccine Development?

Upstream Bio to target asthma as it launches with $200M financing

UK Partnership is looking for new Epigenetic targets in Respiratory Disease

Replay Bio launches HSV gene therapy company to target retinal eye disease

Collaboration to explore gene therapy products for neurodegenerative disorders

Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing

Swiss Biotech Raises €20M to Develop Decoy Drugs in Autoimmune Disease

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

The Return of Gene Therapy

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!